First reported case of unexpected response to an epidermal growth factor receptor tyrosine kinase inhibitor in the I744M uncommon EGFR mutation

Emmanuelle Kempf, Ludovic Lacroix, Jean Charles Soria

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)e259-e261
    JournalClinical Lung Cancer
    Volume16
    Issue number6
    DOIs
    Publication statusPublished - 1 Nov 2015

    Keywords

    • Gefitinib
    • I744M mutation
    • Non-small-cell lung cancer
    • Oncogene addiction
    • Rare EGFR mutation

    Cite this